HISTIOCYTOSIS
Clinical trials for HISTIOCYTOSIS explained in plain language.
Never miss a new study
Get alerted when new HISTIOCYTOSIS trials appear
Sign up with your email to follow new studies for HISTIOCYTOSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for kids with rare immune disorder after other treatments fail
Disease control Recruiting nowThis study aims to find the safest and most effective way to use the drug trametinib for children with a rare immune system disorder called histiocytosis. It is for kids whose disease has not responded to standard treatments or a previous targeted drug, and who do not have a spec…
Matched conditions: HISTIOCYTOSIS
Phase: PHASE2 • Sponsor: Anna Raciborska • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
New pill targets 'Undruggable' cancer mutations in major trial
Disease control Recruiting nowThis study is testing a new oral drug, S241656, alone and in combination with other cancer therapies. It aims to find a safe and effective dose for adults with advanced cancers, including lung, pancreatic, and colorectal cancers, that have specific genetic mutations like KRAS or …
Matched conditions: HISTIOCYTOSIS
Phase: PHASE1, PHASE2 • Sponsor: Institut de Recherches Internationales Servier • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
Scientists hunt for better ways to track a rare childhood disease
Knowledge-focused Recruiting nowThis study aims to improve the diagnosis and monitoring of histiocytosis, a rare disease in children where certain immune cells grow out of control. Researchers will test how well PET-CT scans work and analyze DNA from tumors and blood to understand the disease better and track i…
Matched conditions: HISTIOCYTOSIS
Phase: PHASE3 • Sponsor: Anna Raciborska • Aim: Knowledge-focused
Last updated Mar 27, 2026 12:40 UTC